Nicolas Nottet

Nicolas Nottet

Auto-generated profile, based on publicly available information

Nicolas Nottet

INSERM U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Université Côte d'Azur, Nice, France

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2019 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
GSGrégoire Savary
Grégoire Savary
EDEdmone Dewaeles
Edmone Dewaeles
SDSerena Diazzi
Serena Diazzi
MBMatthieu Buscot
Matthieu Buscot
NNNicolas Nottet
Nicolas Nottet
NPnicolas pottier
nicolas pottier
Rationale: Given the paucity of effective treatments for idiopathic pulmonary fibrosis (IPF), new insights into the deleterious mechanisms controlling lung fibroblast activation, the key cell type driving the fibrogenic process, are essential to develop new therapeutic strategies. TGF-β (transforming growth factor-β) is the main profibrotic factor, but its inhibition is associated with severe side effects because of its pleiotropic role. Objectives: To determine if downstream noncoding effectors of TGF-β in fibroblasts may represent new effective therapeutic targets whose modulation may be well tolerated. Methods: We investigated the whole noncoding fraction of TGF-β–stimulated lung fibroblast transcriptome to identify new genomic determinants of lung fibroblast differentiation into myofibroblasts. Differential expression of the long noncoding RNA (lncRNA) DNM3OS (dynamin 3 opposite strand) and its associated microRNAs (miRNAs) was validated in a murine model of pulmonary fibrosis and in IPF tissue samples. Distinct and complementary antisense oligonucleotide–based strategies aiming at interfering with DNM3OS were used to elucidate the role of DNM3OS and its associated miRNAs in IPF pathogenesis. Measurements and Main Results: We identified DNM3OS as a fibroblast-specific critical downstream effector of TGF-β–induced lung myofibroblast activation. Mechanistically, DNM3OS regulates this process in trans by giving rise to three distinct profibrotic mature miRNAs (i.e., miR-199a-5p/3p and miR-214-3p), which influence SMAD and non-SMAD components of TGF-β signaling in a multifaceted way. In vivo, we showed that interfering with DNM3OS function not only prevents lung fibrosis but also improves established pulmonary fibrosis. Conclusions: Pharmacological approaches aiming at interfering with the lncRNA DNM3OS may represent new effective therapeutic strategies in IPF.

15 August 2019 in Oncogene
Verified
Journal Article
Closed access
LLLaura Moreno Leon
Laura Moreno Leon
MGMarine Gautier
Marine Gautier
RARichard Allan
Richard Allan
Marius IliéMarius Ilié
Marius Ilié
NNNicolas Nottet
Nicolas Nottet
RRRoger Rezzonico
Roger Rezzonico

31 October 2013 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
EDEtienne GJ Danchin
Etienne GJ Danchin
MAMarie-Jeanne Arguel
Marie-Jeanne Arguel
ACAmandine Campan-Fournier
Amandine Campan-Fournier
LPLaetitia Perfus-Barbeoch
Laetitia Perfus-Barbeoch
MMMarc Magliano
Marc Magliano
PAPierre Abad
Pierre Abad
Root-knot nematodes are globally the most aggressive and damaging plant-parasitic nematodes. Chemical nematicides have so far constituted the most efficient control measures against these agricultural pests. Because of their toxicity for the environment and danger for human health, these nematicides have now been banned from use. Consequently, new and more specific control means, safe for the environment and human health, are urgently needed to avoid worldwide proliferation of these devastating plant-parasites. Mining the genomes of root-knot nematodes through an evolutionary and comparative genomics approach, we identified and analyzed 15,952 nematode genes conserved in genomes of plant-damaging species but absent from non target genomes of chordates, plants, annelids, insect pollinators and mollusks. Functional annotation of the corresponding proteins revealed a relative abundance of putative transcription factors in this parasite-specific set compared to whole proteomes of root-knot nematodes. This may point to important and specific regulators of genes involved in parasitism. Because these nematodes are known to secrete effector proteins in planta, essential for parasitism, we searched and identified 993 such effector-like proteins absent from non-target species. Aiming at identifying novel targets for the development of future control methods, we biologically tested the effect of inactivation of the corresponding genes through RNA interference. A total of 15 novel effector-like proteins and one putative transcription factor compatible with the design of siRNAs were present as non-redundant genes and had transcriptional support in the model root-knot nematode Meloidogyne incognita. Infestation assays with siRNA-treated M. incognita on tomato plants showed significant and reproducible reduction of the infestation for 12 of the 16 tested genes compared to control nematodes. These 12 novel genes, showing efficient reduction of parasitism when silenced, constitute promising targets for the development of more specific and safer control means. Plant-parasitic nematodes are annually responsible for more than $100 billion crop yield loss worldwide and those considered as causing most of the damages are root-knot nematodes. These nematodes used to be controlled by chemicals that are now banned from use because of their poor specificity and high toxicity for the environment and human health. In the absence of sustainable alternative solutions, new control means, more specifically targeted against these nematodes and safe for the environment are needed. We searched in root-knot nematode genomes, genes conserved in various plant-damaging species while otherwise absent from the genomes of non target species such as those of chordates, plants, annelids, insect pollinators and mollusks. These genes are probably important for plant parasitism and their absence from non-target species make them interesting candidates for the development of more specific and safer control means. Further bioinformatics pruning of this set of genes yielded 16 novel candidates that could be biologically tested. Using RNA interference, we knocked down each of these 16 genes in a root-knot nematode and tested the effect on plant parasitism efficiency. Out of the 16 tested genes, 12 showed a significant and reproducible diminution of infestation when silenced and are thus particularly promising.

16 October 2017 in New Phytologist
Verified
Journal Article
Closed access
NNNGUYEN Chinh Chinh Nghia
NGUYEN Chinh Chinh Nghia
LPLaetitia Perfus‐Barbeoch
Laetitia Perfus‐Barbeoch
MQMichaël Quentin
Michaël Quentin
Jianlong ZhaoJianlong Zhao
Jianlong Zhao
MMMarc Magliano
Marc Magliano
BFBruno Favery
Bruno Favery

18 January 2021 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
CPCharlotte Pandiani
Charlotte Pandiani
TSThomas Strub
Thomas Strub
NNNicolas Nottet
Nicolas Nottet
YCYann Cheli
Yann Cheli
GGGiovanni Gambi
Giovanni Gambi
CBCorine Bertolotto
Corine Bertolotto

1 March 2018 in Genes & Development
Verified
Journal Article
Open access
PDF file
MOMickaël Ohanna
Mickaël Ohanna
MCMichael CEREZO
Michael CEREZO
NNNicolas Nottet
Nicolas Nottet
KBKarine Bille
Karine Bille
RDRobin Didier
Robin Didier
CBCorine Bertolotto
Corine Bertolotto
In BRAFV600E melanoma cells, a global metabolomic analysis discloses a decrease in nicotinamide adenine dinucleotide (NAD+) levels upon PLX4032 treatment that is conveyed by a STAT5 inhibition and a transcriptional regulation of the nicotinamide phosphoribosyltransferase (NAMPT) gene. NAMPT inhibition decreases melanoma cell proliferation both in vitro and in vivo, while forced NAMPT expression renders melanoma cells resistant to PLX4032. NAMPT expression induces transcriptomic and epigenetic reshufflings that steer melanoma cells toward an invasive phenotype associated with resistance to targeted therapies and immunotherapies. Therefore, NAMPT, the key enzyme in the NAD+ salvage pathway, appears as a rational target in targeted therapy-resistant melanoma cells and a key player in phenotypic plasticity of melanoma cells.